TELA Bio Revenue Falls 8% as Company Cuts Costs
MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) reported an 8% decline in third-quarter revenue to $19 million as weaker sales of its reconstructive surgery products weighed on results, prompting …
TELA Bio Revenue Falls 8% as Company Cuts Costs Read More